KOSDAQ · Technology · ₩20B
₩2,165+1.17%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 1.5% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“제약이 중심이 됐고, 광 사업이 다음 성장축이에요.”
In the company's words · 2026 2분기 filing